conjunctivitis%20-%20viral
CONJUNCTIVITIS - VIRAL
Viral conjunctivitis is the inflammation of the conjunctiva of viral etiology.
Signs and symptoms include unilateral or bilateral eye redness, foreign body sensation and follicular conjunctival reaction.
It may be caused by adenovirus, herpes simplex or molluscum contagiosum.
Drug Information

Indication: Treatment & prevention of herpes simplex virus infections, genital herpes of skin & mucous membranes &...

Indication: Herpes simplex virus infections of skin & mucous membranes including initial & recurrent genital herpe...

Dosage: Adult Herpes simplex infections 200 mg 5 times daily at 4-hrly intervals for 5 days. Severely immunocompromise

Indication: Management of acute & chronic anterior uveitis, iridocyclitis, iritis & cyclitis, herpes zoster ophtha...

Indication: Relief of ocular irritation, congestion & treatment of allergic or inflammatory ocular conditions.

Indication: Temporary prevention of eye itching due to allergic conjunctivitis.

Indication: Allergic conjunctivitis.

Indication: Treatment & prophylaxis of herpes genitalis, treatment of herpes zoster, herpes simples & varicella (chickenpo...

Shinallerg
antazoline hydrochloride + tetryzoline hydrochlori...

Indication: Non-infectious irritative conjunctivitis, allergic-inflammatory conjunctival affections, hay fever & conju...

Indication: Varicella-zoster viral infections. Skin & mucous membrane infections due to herpes simplex virus. Prophyla...

1  /  5
Editor's Recommendations
Most Read Articles
Pearl Toh, 5 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.